Medical Technology

@tech.eu 2 years ago

Why biotech investors are attracted to Lithuania

@xconomy.com 3 years ago

Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs

@xconomy.com 3 years ago

AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact

@xconomy.com 3 years ago

Two Days, Six IPOs, and $1B Raised for Biotech Research & More

@xconomy.com 3 years ago

Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs

@xconomy.com 4 years ago

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

@xconomy.com 4 years ago

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

@xconomy.com 4 years ago

Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery

@xconomy.com 4 years ago

Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic

@xconomy.com 4 years ago

Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 4 years ago

San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak

@xconomy.com 5 years ago

UT Health San Antonio Plans New Accelerator for Faculty Research

@xconomy.com 5 years ago

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

@xconomy.com 5 years ago

Nominations Open for San Diego’s Inaugural Xconomy Awards

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More